Breast cancer in the male: A report of 138 cases

Open Access
Publisher Website
Google Scholar
Abstract
This is a report of 138 male patients with cancer of the breast who were treated at the Hellenic Anticancer Institute from 1937 to 1974. The overall 5‐year survival rate for 120 patients followed up was 32.5%. Analysis of the 5‐year survival rate in relation to the mode of treatment showed that for radical mastectomy it was 42.9%, for simple mastectomy 40.7%, and for lumpectomy 35%. There were no 5‐year survivors among patients treated with a combination of radiotherapy, chemotherapy, and hormonal manipulation. The 5‐year survival rate for stage I cancer was 54.6%, for stage II the rate was 48.7%, and for stage III it was 18.5%. There were no 5‐year survivors with stage IV cancer. The 5‐year survival rate for patients who underwent radical mastectomy with positive axillary lymph nodes was 30.8%, while for those in whom the axillary lymph nodes were negative it was 56.5%. The overall 10‐year survival rate was 14.8%.